Colowide Co.,Ltd.

2026/08/21 Updated
Market Cap: $1.3B (¥213.8B)
Stock Price: $12.65 (¥2,012)
Exchange Rate: 1 USD = ¥158.98

Unknown

There has been a correction to the consolidated results for the Fiscal Year ending March 2026, with revenue revised to 300,090 million yen and EBITDA to 22,538 million yen. The projections for the Fiscal Year ending March 2027 have also been revised, with sales expected to be 351,642 million yen and EBITDA 27,748 million yen.

Importance:
Page Updated: May 18, 2026
IR Disclosure Date: May 18, 2026

Key Figures

  • Sales Revenue: 300,090 million yen (Up 11.5% YoY)
  • EBITDA: 22,538 million yen (Up 21.9% YoY)
  • Net Income Attributable to Owners of Parent: 2,233 million yen (Up 78.7% YoY)

AI要約

Performance Overview

This document communicates the correction regarding the consolidated results for the Fiscal Year ending March 2026, with sales revenue revised to 300,090 million yen, operating profit to 12,527 million yen, and EBITDA to 22,538 million yen. Compared to the same period last year, sales increased by 11.5%, EBITDA rose by 21.9%, and net profit significantly improved. The figures for the Fiscal Year ending March 2025 have also been revised, with sales at 269,156 million yen and EBITDA at 18,486 million yen. The forecast for the Fiscal Year ending March 2027 has been updated to sales of 351,642 million yen and EBITDA of 27,748 million yen.

Future Outlook and Impact

According to the correction, the upward trend in sales and EBITDA continues, with the projections for March 2027 indicating sustained growth. This should enhance investor confidence in the company's profitability and financial health. The correction mainly stems from errors in EBITDA calculation, which should strengthen the reliability of the future performance outlook.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Colowide

Company overview · Stock price · Financial data · All IR

View company page →